Pub. 1 Issue 3

GLANCDA Board Director Peter Hoff- man presents City of Hope with a do- nation. The event had over 7,000 par - ticipants, and raised nearly one million dollars! gynecological cancers, and prevention of disease among women at risk,” said Joanne Mortimer, M.D., director of City of Hope’s Women’s Cancers Program. “We are grateful for the funding we have received through Walk for Hope. This generous support enables us to provide a continuum of care – from research to risk assessment, prevention, treatment, education and survivorship.” This year, the power and emotion of Walk for Hope Los Angeles were shared before the event even started. Us- ing the hashtag #whyIwalk, participants creating short, personal videos across Twitter, Instagram, Vine and Face- book explaining the reason they take part in the walk. Some walked for a lost loved one, some walked to cel- ebrate their own victory over cancer, but all have a deeply personal reason. #Walk4Hope was the general hashtag for the event. Fueling participants is the knowledge of the research currently be- ing conducted at City of Hope. Some researchers in theWomen’s Cancers Program are investigat- ing the biology of breast, ovarian and endometrial cancers or interventions that could reduce cancer risk for all women. Oth- ers are identifying new treatments and preven- tion methods. And still others are examining is- sues that affect women with cancer and their families, such as spiri- tuality, the emotional impact of cancer on care- givers, and other quality-of-life issues. To learn more about City of Hope’s Women’s Cancers Program, visit http://womenscancers. cityofhope.org .  O ne in three women will be diagnosed with can- cer in her lifetime. On Sunday, Nov. 3, this real- ity united thousands of survivors, families and friends in a truly one-of-a-kind event: City of Hope’s Walk for Hope, presented by Staples. The walk not only raises funds for research into women’s cancers, it’s actually held where new treatments are found and where they save lives: on the City of Hope campus in Duarte, with cancer pa- tients watching from the windows of the nationally known Helford Hospital. The annual event, a moving tribute to those women who have been, and will be, affected by women’s cancers, supports City of Hope’s multidisciplinary Women’s Cancers Program. It’s the signature event of the nation’s Walk for Hope series, the only series that benefits research, treatment and education programs for all cancers unique to women. Most special about the event is the location. Walkers feel the power of their contribution as they walk by City of Hope’s renowned Beckman Research Institute, where promis- ing scientific discoveries are made. The emotion is amplified as they wave and cheer to patients currently undergoing treatment. Participants have called the experience “overwhelmingly power- ful” and “incredibly moving.” With more than 8,000 walkers on the campus, Walk for Hope Los Angeles celebrates the collaboration between researchers, patients and the community to bring an end to women’s cancers. “City of Hope’sWomen’s Cancers Program conducts innovative re- search to provide effective interventions for women with breast and GLANCDA’s 15th Year Participating and Sponsoring Walk for Hope 6